{"id":"NCT02456740","sponsor":"Amgen","briefTitle":"Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention","officialTitle":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-07-17","primaryCompletion":"2016-09-05","completion":"2017-06-19","firstPosted":"2015-05-28","resultsPosted":"2018-07-10","lastUpdate":"2022-10-12"},"enrollment":955,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine"],"interventions":[{"type":"DRUG","name":"Erenumab","otherNames":["AMG 334","Aimovig™"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Erenumab 70 mg QM","type":"EXPERIMENTAL"},{"label":"Erenumab 140 mg QM","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study was to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days.","primaryOutcome":{"measure":"Change From Baseline in Mean Monthly Migraine Days to the Last 3 Months of the Double-blind Treatment Period","timeFrame":"4-week baseline phase and the last 3 months (months 4, 5, and 6) of the 24-week double-blind treatment phase","effectByArm":[{"arm":"Placebo","deltaMin":-1.83,"sd":0.18},{"arm":"Erenumab 70 mg QM","deltaMin":-3.23,"sd":0.18},{"arm":"Erenumab 140 mg QM","deltaMin":-3.67,"sd":0.18}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"},{"comp":"OG000 vs OG002","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":129,"countries":["United States","Austria","Belgium","Canada","Czechia","Finland","Germany","Netherlands","Poland","Slovakia","Sweden","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["30086681","29171821","35272533","35137394","34841526","31707815","31852816","34407654","33315334","35978286","34928306","34301173","33939497","32851644","32746775","32636324"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":319},"commonTop":["Viral upper respiratory tract infection","Upper respiratory tract infection"]}}